Variables | Experiment 1, TG transfluthrin- (5.25Â g) | Experiment 2, EC transfluthrin (5.25Â g) | Experiment 3, EC transfluthrin (5.25Â g) | |||
---|---|---|---|---|---|---|
OR* | P-value | ORa | P-value | ORa | P-value | |
Treatment | ||||||
 Control | 1 |  | 1 |  | 1 |  |
 Transfluthrin | 0.22 (0.18–0.26) | < 0.001 | 0.10 (0.08–0.12) | < 0.001 | 0.14 (0.12–0.17) | < 0.001 |
Strain (in control) | ||||||
 Ifakara strain (susceptible) | 1 |  | 1 |  |  |  |
 Mbita strain (metabolic) | 0.43 (0.32–0.57) | < 0.001 | 0.34 (0.26–0.46) | < 0.001 | – | – |
 Kingani strain (metabolic) | 0.60 (0.45–0.80) | < 0.001 | 0.44 (0.33–0.59) | < 0.001 | – | – |
 Kisumu susceptible | – | – | – | – | 1 |  |
 Kisumu kdr | – | – | – | – | 1.0 (0.86–1.17) | 0.05 |
Volunteers | ||||||
 Volunteer 1 | 1 |  | 1 |  | 1 |  |
 Volunteer 2 | 0.88 (0.69–1.14) | 0.36 | 1.07 (0.84–1.39) | 0.60 | 1.20 (0.99–1.46) | 0.06 |
 Volunteer 3 | 0.76 (0.59–0.98) | 0.04 | 0.96 (0.74–1.24) | 0.77 | 1.19 (0.98–1.44) | 0.07 |
 Volunteer 4 | 0.83 (0.72–0.95) | 0.001 | 0.90 (0.78–1.04) | 0.17 | 1.14 (0.94–1.36) | 0.18 |
Compartment | ||||||
 Compart 1 | 1 |  | 1 |  | 1 |  |
 Compart 2 | 0.90 (0.81–0.99) | 0.04 | 0.79 (0.71–0.87) | < 0.001 | 0.93 (0.81–1.07) | 0.30 |
Treatment * strain | ||||||
 Transfluthrin * Ifakara strain | 1 |  | 1 |  |  |  |
 Transfluthrin * Mbita strain | 1.50 (1.18–1.91) | < 0.001 | 1.67 (1.29–2.17) | < 0.001 | – | – |
 Transfluthrin * Kingani strain | 1.03 (0.82–1.32) | 0.75 | 2.29 (1.78–2.94) | < 0.001 | – | – |
 Transfluthrin * Kisumu susceptible | – | – | – | – | 1 |  |
 Transfluthrin * Kisumu kdr | – | – | – | – | 0.98 (0.74–1.30) | 0.90 |